What drives moves in 3SMO.PA stock?

3SMO.PA stock tracks a 3x inverse exposure to Moderna (MRNA). Moves are driven by MRNA price action, market gaps, and intraday volatility. Leverage and daily resetting magnify gains and losses, so short-term MRNA news, earnings, or sector rotation move 3SMO.PA rapidly.

Is 3SMO.PA stock suitable for buy-and-hold investors?

No. 3SMO.PA stock is a leveraged inverse ETP intended for short-term tactical trading. Daily reset and path dependency produce performance drag over multi-day holds, increasing risk for buy-and-hold strategies.

How should I manage risk trading 3SMO.PA stock?

Manage risk with tight position sizing, limit orders to control slippage, and stop-loss rules. Monitor underlying MRNA moves, watch liquidity (current volume **3.00** vs average **29.00**) and expect rapid price swings in pre-market and open sessions.

EU Stocks

3SMO.PA €632.53 +9.93%: GraniteShares 3x Short Moderna EURONEXT 16 Jan 2026 note

ByDanny Kontos January 16, 2026

Pre-market action shows 3SMO.PA stock trading at €632.53, up +9.93% as of this session on EURONEXT (Europe) on 16 Jan 2026. The GraniteShares 3x Short Moderna ETP rose from an open of €576.00 to a intra-session high of €632.53, but reported volume of 3.00 versus an average volume of 29.00, signalling extremely thin liquidity. This move follows volatility in underlying Moderna (MRNA) shares and reflects leveraged intraday exposure. Investors should treat short-leveraged ETPs as high-risk, short-term instruments rather than buy-and-hold holdings.